Linda D. Bradley

No ORCID on file · 5 papers in corpus · active 2000-2022

Study types

  • article 4
  • review 1

Condition tags

  • adenomyosis 2
  • mesh:D004715 1
  • endometriosis 1
article 2022
Racial and ethnic disparities in surgical care for endometriosis across the United States
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2022.01.021
article 2021
Efficacy and safety of elagolix with add-back therapy in women with uterine fibroids and coexisting adenomyosis
F&S reports ·doi:10.1016/j.xfre.2021.05.004

OBJECTIVE: To determine if coexisting adenomyosis limits the efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy in reducing heavy menstrual bleeding in women with uterine fibroids. DESIGN…

article 2020
Effect of Elagolix on Menstrual Blood Loss in Women With Uterine Fibroids and Adenomyosis [15B]
·doi:10.1097/01.aog.0000663140.66314.38

INTRODUCTION: Evaluate the efficacy of elagolix with add-back therapy on menstrual blood loss (MBL) and safety in women with uterine fibroids (UF), heavy menstrual bleeding (HMB) and adenomyosis. METHODS: Pooled data from two investigationa…

article 2019
Effect of fibroid location and size on efficacy of elagolix: results from phase 3 clinical trials
·doi:10.1016/j.fertnstert.2019.07.344
review 2000
Radiographic imaging techniques for the diagnosis of abnormal uterine bleeding
Obstetrics and gynecology clinics of North America ·doi:10.1016/s0889-8545(00)80019-4